Cerner Corporation (CERN) was reiterated an ‘Outperform’ by RBC Capital Markets analysts on Wednesday. The broker also raised its price target on the stock to $70 from $65. — In a report published Wednesday, Chardan Capital Markets analysts initiated coverage on Ritter Pharmaceuticals, Inc. (RTTR) with a ‘Buy’ rating and $3.00 price target. RTTR has […]
View the full post at: Notable Upgrades: Cerner (CERN), Ritter Pharmaceuticals (RTTR), Bristol-Myers Squibb (BMY), Orbotech (ORBK)
